Contract

Academic research: Review of children & adolescent gender identity services

  • NHS England

F20: Modification notice

Notice identifier: 2023/S 000-032508

Procurement identifier (OCID): ocds-h6vhtk-029499

Published 2 November 2023, 5:09pm



Section one: Contracting authority/entity

one.1) Name and addresses

NHS England

Quarry House, Quarry Hill

Leeds

LS2 7UE

Contact

Commercial Contract Management Team

Email

england.commercialqueries@nhs.net

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)

Main address

https://www.england.nhs.uk/

Buyer's address

https://www.england.nhs.uk/


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Academic research: Review of children & adolescent gender identity services

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement at the time of conclusion of the contract:

NHS England and Improvement recently announced an independent review into children and adolescent gender identity development services (for under 17s) which is commissioned by NHS England’s specialised commissioning directorate - (ToR of review - https://www.england.nhs.uk/wp-content/uploads/2020/09/GIDS_independent_review_ToR.pdf.).

This review requires extensive, expert led research and engagement in order to successfully make recommendations to inform the future shape of gender identity development services for children and young people.

A key principle of the review is that it must be participative, evidence based and incorporate lived experience in order to formulate conclusions and recommendations that will command the confidence of stakeholders.

The research streams outlined in this specification have been designed to achieve these ends. Specifically, the outputs required are to achieve the best available collation of published evidence, and qualitative and quantitative research that can feasibly be produced within the timeframe of the review.

Recognising that the published evidence is unlikely to be of high enough quality to form the sole basis for the recommendations of the review, a process is needed for synthesising the published evidence and research outputs of the academic team(s) with stakeholder submissions and expert opinion. This will involve a consensus development approach, using Delphi or other appropriate tools, and we would anticipate that the research team(s) would be integral to this important stage of the review.

The review will report to NHS England’s Commissioning Committee and a project assurance group, Chaired by Dr Cass has been set up to oversee the work. The project assurance group will assist the Chair in ensuring the process and conduct of review is appropriate, fit for purpose and that decisions are transparent. The assurance group does not contain subject matter experts or service users and their role is strictly the governance of the review process, not to inform outcome. The group includes ethics, legal, and research expertise, plus experience in CYP advocacy, and CYP participation.

two.2.7) Duration of the contract, framework agreement, dynamic purchasing system or concession

Start date

8 September 2021

End date

8 January 2024

two.2.13) Information about European Union Funds

The procurement is related to a project and/or programme financed by European Union funds: No


Section four. Procedure

four.2) Administrative information

four.2.1) Contract award notice concerning this contract

Notice number: 2021/S 000-008342


Section five. Award of contract/concession

Contract No

1

Title

Academic research: Review of children & adolescent gender identity services

five.2) Award of contract/concession

five.2.1) Date of conclusion of the contract/concession award decision:

8 September 2021

five.2.2) Information about tenders

The contract/concession has been awarded to a group of economic operators: No

five.2.3) Name and address of the contractor/concessionaire

University of York

Heslington, York

York

YO10 5DD

Country

United Kingdom

NUTS code
  • UK - United Kingdom
National registration number

RC000679

Internet address

http://www.york.ac.uk

The contractor/concessionaire is an SME

No

five.2.4) Information on value of the contract/lot/concession (at the time of conclusion of the contract;excluding VAT)

Total value of the procurement: £897,512


Section six. Complementary information

six.4) Procedures for review

six.4.1) Review body

The High Court

The Strand

London

WC2A 2LL

Country

United Kingdom

Internet address

https://www.judiciary.uk/courts-and-tribunals/high-court/

six.4.2) Body responsible for mediation procedures

NHS England

1st Floor, Quarry House, Quarry Hill

Leeds

LS2 7UE

Country

United Kingdom

Internet address

https://www.england.nhs.uk//


Section seven: Modifications to the contract/concession

seven.1) Description of the procurement after the modifications

seven.1.1) Main CPV code

  • 85100000 - Health services

seven.1.3) Place of performance

NUTS code
  • UK - United Kingdom

seven.1.4) Description of the procurement:

NHS England and Improvement recently announced an independent review into children and adolescent gender identity development services (for under 17s) which is commissioned by NHS England’s specialised commissioning directorate - (ToR of review - https://www.england.nhs.uk/wp-content/uploads/2020/09/GIDS_independent_review_ToR.pdf.).

This review requires extensive, expert led research and engagement in order to successfully make recommendations to inform the future shape of gender identity development services for children and young people.

A key principle of the review is that it must be participative, evidence based and incorporate lived experience in order to formulate conclusions and recommendations that will command the confidence of stakeholders.

The research streams outlined in this specification have been designed to achieve these ends. Specifically, the outputs required are to achieve the best available collation of published evidence, and qualitative and quantitative research that can feasibly be produced within the timeframe of the review.

Recognising that the published evidence is unlikely to be of high enough quality to form the sole basis for the recommendations of the review, a process is needed for synthesising the published evidence and research outputs of the academic team(s) with stakeholder submissions and expert opinion. This will involve a consensus development approach, using Delphi or other appropriate tools, and we would anticipate that the research team(s) would be integral to this important stage of the review.

The review will report to NHS England’s Commissioning Committee and a project assurance group, Chaired by Dr Cass has been set up to oversee the work. The project assurance group will assist the Chair in ensuring the process and conduct of review is appropriate, fit for purpose and that decisions are transparent. The assurance group does not contain subject matter experts or service users and their role is strictly the governance of the review process, not to inform outcome. The group includes ethics, legal, and research expertise, plus experience in CYP advocacy, and CYP participation.

seven.1.5) Duration of the contract, framework agreement, dynamic purchasing system or concession

Start date

8 September 2021

End date

8 January 2024

seven.1.6) Information on value of the contract/lot/concession (excluding VAT)

Total value of the contract/lot/concession:

£1,227,114

seven.1.7) Name and address of the contractor/concessionaire

University of York

Heslington, York

York

YO10 5DD

Country

United Kingdom

NUTS code
  • UK - United Kingdom
National registration number

RC000679

Internet address

http://www.york.ac.uk

The contractor/concessionaire is an SME

No

seven.2) Information about modifications

seven.2.1) Description of the modifications

Nature and extent of the modifications (with indication of possible earlier changes to the contract):

Contract variation of value: £329,602

Zero-cost contract extensions from the original contract end date to 08/01/2024

seven.2.2) Reasons for modification

Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee.

Description of the circumstances which rendered the modification necessary and explanation of the unforeseen nature of these circumstances:

Both the contract variation of £329,602 and contract extensions were due to the Statutory Instrument necessary to undertake part of the work.

seven.2.3) Increase in price

Updated total contract value before the modifications (taking into account possible earlier contract modifications, price adaptions and average inflation)

Value excluding VAT: £897,512

Total contract value after the modifications

Value excluding VAT: £1,227,114